Cargando…

Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans

Central hypovolemia elevates hemostatic activity which is essential for preventing exsanguination after trauma, but platelet activation to central hypovolemia has not been described. We hypothesized that central hypovolemia induced by lower body negative pressure (LBNP) activates platelets. Eight he...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaar, Morten, Fedyk, Chriselda G., Pidcoke, Heather F., Scherer, Michael R., Ryan, Kathy L., Rickards, Caroline A., Hinojosa-Laborde, Carmen, Convertino, Victor A., Cap, Andrew P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278859/
https://www.ncbi.nlm.nih.gov/pubmed/25546432
http://dx.doi.org/10.1371/journal.pone.0116174
_version_ 1782350587657977856
author Zaar, Morten
Fedyk, Chriselda G.
Pidcoke, Heather F.
Scherer, Michael R.
Ryan, Kathy L.
Rickards, Caroline A.
Hinojosa-Laborde, Carmen
Convertino, Victor A.
Cap, Andrew P.
author_facet Zaar, Morten
Fedyk, Chriselda G.
Pidcoke, Heather F.
Scherer, Michael R.
Ryan, Kathy L.
Rickards, Caroline A.
Hinojosa-Laborde, Carmen
Convertino, Victor A.
Cap, Andrew P.
author_sort Zaar, Morten
collection PubMed
description Central hypovolemia elevates hemostatic activity which is essential for preventing exsanguination after trauma, but platelet activation to central hypovolemia has not been described. We hypothesized that central hypovolemia induced by lower body negative pressure (LBNP) activates platelets. Eight healthy subjects were exposed to progressive central hypovolemia by LBNP until presyncope. At baseline and 5 min after presyncope, hemostatic activity of venous blood was evaluated by flow cytometry, thrombelastography, and plasma markers of coagulation and fibrinolysis. Cell counts were also determined. Flow cytometry revealed that LBNP increased mean fluorescence intensity of PAC-1 by 1959±455 units (P<0.001) and percent of fluorescence-positive platelets by 27±18%-points (P = 0.013). Thrombelastography demonstrated that coagulation was accelerated (R-time decreased by 0.8±0.4 min (P = 0.001)) and that clot lysis increased (LY(60) by 6.0±5.8%-points (P = 0.034)). Plasma coagulation factor VIII and von Willebrand factor ristocetin cofactor activity increased (P = 0.011 and P = 0.024, respectively), demonstrating increased coagulation activity, while von Willebrand factor antigen was unchanged. Plasma protein C activity and tissue-type plasminogen activator increased (P = 0.007 and P = 0.017, respectively), and D-dimer increased by 0.03±0.02 mg l(−1) (P = 0.031), demonstrating increased fibrinolytic activity. Plasma prothrombin time and activated partial thromboplastin time were unchanged. Platelet count increased by 15±13% (P = 0.014) and red blood cells by 9±4% (P = 0.002). In humans, LBNP-induced presyncope activates platelets, as evidenced by increased exposure of active glycoprotein IIb/IIIa, accelerates coagulation. LBNP activates fibrinolysis, similar to hemorrhage, but does not alter coagulation screening tests, such as prothrombin time and activated partial thromboplastin time. LBNP results in increased platelet counts, but also in hemoconcentration.
format Online
Article
Text
id pubmed-4278859
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42788592015-01-05 Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans Zaar, Morten Fedyk, Chriselda G. Pidcoke, Heather F. Scherer, Michael R. Ryan, Kathy L. Rickards, Caroline A. Hinojosa-Laborde, Carmen Convertino, Victor A. Cap, Andrew P. PLoS One Research Article Central hypovolemia elevates hemostatic activity which is essential for preventing exsanguination after trauma, but platelet activation to central hypovolemia has not been described. We hypothesized that central hypovolemia induced by lower body negative pressure (LBNP) activates platelets. Eight healthy subjects were exposed to progressive central hypovolemia by LBNP until presyncope. At baseline and 5 min after presyncope, hemostatic activity of venous blood was evaluated by flow cytometry, thrombelastography, and plasma markers of coagulation and fibrinolysis. Cell counts were also determined. Flow cytometry revealed that LBNP increased mean fluorescence intensity of PAC-1 by 1959±455 units (P<0.001) and percent of fluorescence-positive platelets by 27±18%-points (P = 0.013). Thrombelastography demonstrated that coagulation was accelerated (R-time decreased by 0.8±0.4 min (P = 0.001)) and that clot lysis increased (LY(60) by 6.0±5.8%-points (P = 0.034)). Plasma coagulation factor VIII and von Willebrand factor ristocetin cofactor activity increased (P = 0.011 and P = 0.024, respectively), demonstrating increased coagulation activity, while von Willebrand factor antigen was unchanged. Plasma protein C activity and tissue-type plasminogen activator increased (P = 0.007 and P = 0.017, respectively), and D-dimer increased by 0.03±0.02 mg l(−1) (P = 0.031), demonstrating increased fibrinolytic activity. Plasma prothrombin time and activated partial thromboplastin time were unchanged. Platelet count increased by 15±13% (P = 0.014) and red blood cells by 9±4% (P = 0.002). In humans, LBNP-induced presyncope activates platelets, as evidenced by increased exposure of active glycoprotein IIb/IIIa, accelerates coagulation. LBNP activates fibrinolysis, similar to hemorrhage, but does not alter coagulation screening tests, such as prothrombin time and activated partial thromboplastin time. LBNP results in increased platelet counts, but also in hemoconcentration. Public Library of Science 2014-12-29 /pmc/articles/PMC4278859/ /pubmed/25546432 http://dx.doi.org/10.1371/journal.pone.0116174 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration, which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
spellingShingle Research Article
Zaar, Morten
Fedyk, Chriselda G.
Pidcoke, Heather F.
Scherer, Michael R.
Ryan, Kathy L.
Rickards, Caroline A.
Hinojosa-Laborde, Carmen
Convertino, Victor A.
Cap, Andrew P.
Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans
title Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans
title_full Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans
title_fullStr Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans
title_full_unstemmed Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans
title_short Platelet Activation after Presyncope by Lower Body Negative Pressure in Humans
title_sort platelet activation after presyncope by lower body negative pressure in humans
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278859/
https://www.ncbi.nlm.nih.gov/pubmed/25546432
http://dx.doi.org/10.1371/journal.pone.0116174
work_keys_str_mv AT zaarmorten plateletactivationafterpresyncopebylowerbodynegativepressureinhumans
AT fedykchriseldag plateletactivationafterpresyncopebylowerbodynegativepressureinhumans
AT pidcokeheatherf plateletactivationafterpresyncopebylowerbodynegativepressureinhumans
AT scherermichaelr plateletactivationafterpresyncopebylowerbodynegativepressureinhumans
AT ryankathyl plateletactivationafterpresyncopebylowerbodynegativepressureinhumans
AT rickardscarolinea plateletactivationafterpresyncopebylowerbodynegativepressureinhumans
AT hinojosalabordecarmen plateletactivationafterpresyncopebylowerbodynegativepressureinhumans
AT convertinovictora plateletactivationafterpresyncopebylowerbodynegativepressureinhumans
AT capandrewp plateletactivationafterpresyncopebylowerbodynegativepressureinhumans